In a year of remarkable progress for the Parkinson’s field, we’re entering a new era for better understanding the biology of the disease, with the identification of a breakthrough biomarker accelerating new therapeutics through the clinical pipeline and legislators on Capitol Hill moving toward legislation that unites the federal government on a mission to treat, prevent and cure Parkinson’s disease. 

What does this progress mean for researchers studying Parkinson’s and for those living with the disease? And what will come next? 

Tune in as scientists and staff from The Michael J. Fox Foundation (MJFF) answer these questions and share insights in our latest Third Thursdays Webinar. 

Like our podcasts? Please consider leaving a rating or review and sharing the series with your network. https://apple.co/3p02Jw0  

Join a study today to help speed progress toward better treatments and a cure for Parkinson’s disease. To search for studies in your area, visit Fox Trial Finder at foxtrialfinder.org.  

Whether you have Parkinson’s or not, you can help move research forward. Join the study that’s changing everything. Find out more at michaeljfox.org/podcast-ppmi. 

Mentioned in this episode:

In 2024 alone, The Michael J. Fox Foundation awarded 195 research grants aimed at medication, mobility, medical devices and more to scientists around the world, all in pursuit of better treatments and closing in on a cure. Your support can accelerate this urgent research. Donate by visiting michaeljfox.org/weneedyou.